IBIO

Ibio Inc

$1.00

-0.21 (-17.76%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 20.11.2025
$4.12
(+314.03%)
Strong Buy: 0
Buy: 5
Hold: 0
Sell: 0
Strong Sell: 0
Description:
iBio, Inc. is an innovative biotechnology company headquartered in New York, specializing in plant-based biopharmaceutical production. The company provides contract development and manufacturing services tailored to the production of biologics, including vaccines and therapeutics, thereby positioning itself as a critical partner for organizations both domestically and globally. Leveraging its proprietary technologies, iBio is committed to advancing the efficiency and scalability of biologics manufacturing, effectively addressing the growing demand for sustainable and cost-effective solutions in the dynamic life sciences industry.
Exchange:
NYSE MKT
Country:
USA
Sector:
HEALTHCARE
Industry:
BIOTECHNOLOGY
Address:
11750 SORRENTO VALLEY ROAD, SAN DIEGO, CA, UNITED STATES, 92121
Fiscal year end:
June
Market capitalization:
$24.5 Million
EBITDA:
-$19.7 Million
PERatio:
0.0
EPS:
-1.56
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.119

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
-100%
How much will you get:
$0
Prices dates:
30-10-2015: $3,350.00 and 31-10-2025: $1.60